Regulatory Updates​ Archives – Spark Health Partners https://www.sparkxgroup.cloud/blog/category/regulatory-updates/ Your modern revenue cycle solution Mon, 09 Dec 2024 16:57:35 +0000 en-US hourly 1 ../../../../wp-content/uploads/2023/10/Logo-Chevron-80x80.png Regulatory Updates​ Archives – Spark Health Partners https://www.sparkxgroup.cloud/blog/category/regulatory-updates/ 32 32 Supporting Our Clients Against MA Plans’ 340B Inequities https://www.sparkxgroup.cloud/blog/supporting-our-clients-against-ma-plans-340b-inequities/ Wed, 13 Nov 2024 17:50:06 +0000 https://www.sparkxgroup.cloud/?p=15672 Providers are being ignored by contracted and non-contracted MA plans in their efforts to obtain a remedy for 340B drug underpayments. … Read More

The post Supporting Our Clients Against MA Plans’ 340B Inequities appeared first on Spark Health Partners.

]]>

The 340B Drug Pricing Program is a federal program that allows eligible healthcare facilities, particularly those serving low-income or uninsured patients, to purchase outpatient drugs at significantly reduced prices.

MA plans diverge from CMS guidance on underpayment of claims

In Spark’s experience, the agreed reimbursement rate with Medicare Advantage (MA) plans is nearly always tied to the current Original Medicare rate.

When CMS reduced the reimbursement rate for 340B-acquired drugs between 2018 and 2022, MA plans did the same. Similarly, when CMS restored the original payment rate of ASP + 6% in September 2022, MA plans again followed CMS’s lead. MA plans have not, however, followed CMS’s lead in devising a remedy for the underpayment of claims for 340B-acquired drugs which were paid between 2018 and 2022.

Providers are overwhelmingly being ignored or dismissed by contracted and non-contracted MA plans in their efforts to obtain a remedy for these underpayments. Like their peers, our partner 340B hospitals care for many uninsured or low-income patients and the 340B program allows these hospitals to expand such services to their communities. Pursuing recovery against MA plans for these underpayments can be complex and costly; therefore, providers should ensure they have reviewed their MA plan contracts carefully and evaluated their reimbursement data.

340B concerns are part of a worrying MA plan trend

In the current situation, MA plans have a significant financial incentive to ignore and disregard hospitals until actions are time-barred. While the obvious and primary impact of such tactics may be these underpayments owed to 340B hospitals, the long-term consequences of such tactics from MA plans may impact Medicare Advantage beneficiaries’ continued access to care.

As is known in the healthcare industry, providers and hospitals are exhausted with the costly and administratively burdensome tactics employed by MA plans. From reimbursement cuts to denied and delayed payments to not following Medicare coverage guidelines as required, many providers and facilities are increasingly and understandably choosing not to contract with MA plans or to terminate existing agreements.

As Medicare Advantage enrollment grows, it becomes increasingly important to ensure that MA plans tactics that limit or hinder efficient reimbursement are curtailed so that Medicare Advantage beneficiaries continue to have access to medically necessary care.

Spark continues to support our clients’ right to fair reimbursement

Spark is collaborating with our clients to provide support in pursuing potential recoveries from MA payers for 340B reimbursement. This support includes:

  • Drafting 340B inquiry and demand letters
  • Reviewing and analyzing claims and reimbursement data
  • Researching dispute resolution and arbitration terms to guide clients on their next steps

Additionally, we have partnered with the health care team at the law firm of K&L Gates, LLP, offering our clients one-on-one sessions to discuss the current landscape, evaluate potential actions against payers and address specific questions. The team from K&L Gates, led by partners Andy Ruskin and Gary Qualls, brings decades of provider-side representation experience and significant expertise on 340B issues.

Learn about your options

Contact Spark today to explore a one-on-one session.

The bottom line

The 340B program is vital for many healthcare facilities, enabling them to provide essential services to underserved communities. The current tensions with Medicare Advantage plans highlight the complexities of healthcare reimbursement and the ongoing challenges faced by facilities in navigating these changes.

The post Supporting Our Clients Against MA Plans’ 340B Inequities appeared first on Spark Health Partners.

]]>
Whistleblower Program Incentivizes Reporting of Healthcare Fraud https://www.sparkxgroup.cloud/blog/whistleblower-program-incentivizes-reporting-of-healthcare-fraud/ Mon, 30 Sep 2024 14:18:38 +0000 https://www.sparkxgroup.cloud/?p=14953 A new corporate whistleblower program incentivizes reporting of healthcare fraud involving private insurance plans. … Read More

The post Whistleblower Program Incentivizes Reporting of Healthcare Fraud appeared first on Spark Health Partners.

]]>

A new corporate whistleblower program incentivizes reporting of healthcare fraud involving private insurance plans. Under its statutory authority to pay awards for information or assistance leading to civil or criminal forfeiture, the Criminal Division of the United States Department of Justice (DOJ) recently launched the Corporate Whistleblower Awards Pilot Program to “uncover and prosecute corporate crime.”

This program establishes a new mechanism to identify corporate criminal and civil wrongdoing by whistleblowers as such conduct, as explained by the DOJ, “might otherwise go undetected or be difficult to prove.”

It targets four main subject areas, one of which includes healthcare fraud schemes involving private health insurance plans including fraud against patients, investors and other non-governmental entities in the healthcare industry.

What makes this program unique?

As explained by the DOJ in the FAQ, this whistleblower program fills the gap between fraud involving federal healthcare programs (e.g., Medicare and Medicaid) under the False Claims Act (FCA) qui tam provisions and fraud schemes involving private or other non-public healthcare payers where qui tam does not apply. Unlike the FCA’s qui tam provision, however, this program applies to both criminal and civil acts.

Whistleblowers would need to provide, in writing, original information (as defined in the program) to the DOJ. Where the original information provided leads to a net forfeiture of more than $1 million, the whistleblower may be eligible for an award according to the DOJ’s discretion.

The DOJ’s discretionary criteria indicate that DOJ wishes to first incentivize whistleblowers to report their concerns about potential violations through their internal whistleblower, legal or compliance procedures. Doing so and assisting with their company’s internal investigation are factors DOJ considers for increasing the whistleblower’s award.

Conversely, whistleblowers unreasonably delaying their reporting of potential violations, or interfering with internal compliance and reporting systems, are factors DOJ considers for decreasing the amount of the award.

In its FAQ, the DOJ further explained that this program “complements and strengthens DOJ’s existing “voluntary self-disclosure” (VSD) programs, which offer companies and individuals potential benefits when they self-report their misconduct, remediate the harm, identify responsible individuals and fully cooperate with the government’s investigation.” The DOJ wants to incentivize companies to self-disclose misconduct as soon as they learn of it.

What are the implications for healthcare providers?

Ensure your organization has:

  • Sufficient controls and audit practices in place to identify potentially fraudulent activity for private or other non-public healthcare payers in addition to federal healthcare programs
  • A robust compliance program with whistleblower protections, including non-retaliation policies, and that such programs include prompt and meaningful investigations of reported concerns with follow-up to the whistleblower

For more information on how an effective compliance program should be structured, review the General Compliance Program Guidance issued by the Department of Health and Human Services (HHS) Office of Inspector General (OIG) in November 2023.

Among the seven elements of a compliance program, HHS OIG recommends there be appropriate training and education of requirements and that there be effective lines of communication between the compliance officer and entity personal to reduce the potential of fraud, waste and abuse. Having these measures in place across your organization for all types of payers will reduce your organization’s risk for criminal or civil forfeiture under this new program.

Lastly, if your internal investigation discovers problematic conduct involving private health insurance plans, then the DOJ’s temporary amendment to its Criminal Division’s Corporate Enforcement and Voluntary Self-Disclosure Policy (CEP) allows companies who receive a whistleblower’s report internally to qualify for the presumption of a declination under certain conditions. In such cases, review with your legal counsel to determine your next steps.

Learn more

For more information on the DOJ’s Corporate Whistleblower Awards Pilot Program, visit the DOJ’s website devoted to this new program. See also the associated Fact Sheet and Guidance.

These materials are for general informational purposes only. These materials do not, and are not intended to, constitute legal or compliance advice, and you should not act or refrain from acting based on any information provided in these materials. Neither Spark Health Partners, nor any of its employees, are your lawyers. Please consult with your own legal counsel or compliance professional regarding specific legal or compliance questions you have.

The post Whistleblower Program Incentivizes Reporting of Healthcare Fraud appeared first on Spark Health Partners.

]]>
Tracking Recently Enacted State Laws That Impact the Revenue Cycle https://www.sparkxgroup.cloud/blog/tracking-recently-enacted-state-laws-that-impact-the-revenue-cycle/ Mon, 29 Jul 2024 13:37:54 +0000 https://www.sparkxgroup.cloud/?p=14388 Many bills have been pending in state legislatures. Let’s take a look at what’s been recently enacted in three of those states. … Read More

The post Tracking Recently Enacted State Laws That Impact the Revenue Cycle appeared first on Spark Health Partners.

]]>

Here at Spark Health Partners, our experts keep a close eye on regulatory updates in the healthcare industry that could impact revenue cycle processes. This helps to keep our operators informed as well as to ensure our partners can stay one step ahead of shifting legislation.

In follow-up to our recent article on topics and bills that were pending in state legislatures, let’s take a look at what’s been recently enacted in three of those states.

Florida

Transparency in Health and Human Services:
This legislation includes:

  1. new requirements with respect to the collection of medical debt, including the imposition of a 3-year statute of limitations, and restrictions against taking “extraordinary collection actions” which include preemptively engaging in certain collection actions (e.g. selling debt, credit reporting, etc.) prior to meeting certain requirements (e.g. providing an itemized bill, making reasonable efforts to check eligibility for financial assistance, etc.
  2. new requirements for the provision of good faith estimates*; and
  3. new billing requirements, including required disclosures for cost sharing amounts as compared to cash payments for the same service/item, the establishment of an internal process for reviewing and responding to grievances from patients (the process must also allow a patient to dispute charges that appear on the patient’s itemized statement or bill and provide directions for doing so in bolded print on the bill).

*Note that the requirements for good faith estimates are not effective until the federal government issues a corresponding rule.

Maine

An Act to Provide for Consistent Billing Practices by Health Care Providers:
This new law requires that claims for facility services submitted to health insurance carriers identify the physical location where services are rendered, including hospital off-campus locations.

An Act to Amend the Maine Insurance Code Regarding Payments by Health Insurance Carriers to Providers:
This new law restricts health insurance carriers to filing notices of a proposed amendment to a provider agreement to only four time per calendar year: on January 1, April 1, July 1 and October 1.

If the proposed change is to a reimbursement policy and it will impact more than $500k per year to participating providers, then the notice must include the carrier’s good faith estimate of the total annual financial impact to all participating providers in the state.

Carriers will need to furnish the participating provider with both a clean and redlined copy of the provider agreement being changed. This bill also shortens the time limits for carriers to retroactively deny previously paid claims to not more than 12 months. Situations exempt from the 12-month timeframe will now be subject to a 36-month limit.

An Act to Protect a Patient’s Access to Affordable Health Care with Timely Access to Health Care Prices:
This new law requires health care facilities and practitioners to post a notice informing patients of the right of an uninsured patient to request information about the price of medical services, and to include the notice in the consent-to-treatment form that patients sign before receiving health care services. Upon request of an uninsured or self-pay patient, the new law requires facilities and providers to furnish a good faith estimate of the cost of medical services for that single encounter within specified timeframes.

To a certain extent, these requirements align with current requirements under the Federal No Surprises Act (NSA), and a health care entity does not violate this state law if it complies with NSA requirements. If the provider fails to give an uninsured or self-pay patient a good faith estimate upon their request, then the provider is prohibited from initiating or pursuing any collection action against that patient for those items or services.

This new law also requires the provision of a description of services for a single encounter to insured patients upon their request. The description must include the CPT codes for the services and a notification that the patient may use the estimate to obtain an estimate of their out-of-pocket costs from their health insurance carrier. Carriers are then required to respond to requests from a patient for an estimate based on the description and codes given by the provider.

Lastly, the new law requires hospitals to comply with federal price transparency requirements.

An Act to Prohibit Unfair Practices Related to the Collection of Medical Debt:
This new law prohibits unfair practices related to the collection of patient medical debt, including the collection of any interest or fees on the debt.

If pursuing litigation to compel payment of medical debt, the new law requires providing the patient with a certain written notice indicating that litigation may not be pursued when the consumer’s household income is not more than 300% of the federal poverty level, and then allowing the consumer 30 days to respond and provide evidence of their income.

An Act Concerning Prior Authorizations for Health Care Provider Services:
This new law permits a provider who is actively treating an enrollee to act as their representative for purposes of filing an appeal or grievance without requiring prior authorization from the enrollee. The provider, however, must furnish the enrollee with notice of such at least 14 days prior to filing the appeal or grievance and within 7 days after filing, and the enrollee may affirmatively object to such representation.

This new law requires carriers to allow prior authorizations to be effective for 14 days before or after the approved date if the service cannot be delivered on the approved date. For non-emergency services, the new law prohibits carriers from denying claims for those services so long as they were within the scope of the enrollee’s coverage pending medical necessity review. Carriers may also not impose a penalty on the provider for failing to obtain a prior authorization of greater than 15% of the contractually allowed amount for the services that required prior authorization approval.

This new law prohibits carriers from requiring prior authorization for post-evaluation or post-stabilization services provided during the same encounter. If post-evaluation or post-stabilization services require inpatient care, then the carrier may require prior authorization but it must respond to the prior authorization request within 24 hours. If the provider does not receive a determination within that 24-hour period, then the care is deemed approved until the carrier notifies the provider otherwise.

Lastly, this new law imposes new reporting requirements on carriers relating to prior authorization determinations, which will be collected by the Bureau of Insurance and reported to the Maine Legislature in 2025.

Virginia

An Act relating to health insurance; ethics and fairness in carrier business practices.
This bill made various amendments to Va. Code § 38.2-3407.15, Ethics and Fairness in Carrier Business Practices, including revisions to the definition of a “clean claim.” Regarding retroactive denials of previously paid claims, this was broadened to include any way in which a carrier may seek recovery or refund of a previously paid claim. The time limit is 12 months except that a provider and carrier may agree to longer than 12 months for a retroactive denial. If a carrier’s claim denial is overturned following a dispute review, the carrier must consider the claim be a “clean claim” on the day of its decision.

A newly enacted provision prohibits providers from filing a complaint with the State Corporation Commission for a carrier’s failure to pay claims as required unless the provider attests that they have made a reasonable effort to resolve the issue with the carrier and at least 30 calendar days have passed without response from the carrier.

An Act relating to health insurance; prior authorization.
Requires provider-carrier contracts to include a specific provision that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify or restrict that authorization except in certain limited situations.

An Act relating to reporting of medical debt to consumer reporting agencies by certain health care providers.
Prohibits facilities and providers from reporting any portion of medical debt to a consumer reporting agency. Further, collection entities collecting or attempting to collect a medical debt are prohibited from reporting such collection or attempts to a consumer reporting agency. Any willful violation of this new section constitutes a prohibited practice under the Virginia Consumer Protection Act.

An Act to amend relating to health insurance; health care provider panels; continuity of care.
Requires a provider to continue to render health care services to any of the carrier’s enrollees who have an existing provider-patient relationship with the provider for a period of at least 90 days from the date of a provider’s termination from the carrier’s provider panel. Longer periods required for patients who are pregnant or terminally ill, who have a life-threatening condition or who have been admitted inpatient.

Keeping you informed

Close monitoring of changing regulations is critical for the financial health of our clients and for any healthcare provider. Spark is committed to tracking new legislation as it is drafted and passed. Stay abreast of these latest developments by subscribing to our monthly newsletter, Spark Exclusive.

These materials are for general informational purposes only. These materials do not, and are not intended to, constitute legal or compliance advice, and you should not act or refrain from acting based on any information provided in these materials. Neither Spark Health Partners, nor any of its employees, are your lawyers. Please consult with your own legal counsel or compliance professional regarding specific legal or compliance questions you have.

The post Tracking Recently Enacted State Laws That Impact the Revenue Cycle appeared first on Spark Health Partners.

]]>
Revenue Cycle Impacts: 2024 State Legislation https://www.sparkxgroup.cloud/blog/revenue-cycle-impacts-2024-state-legislation/ Tue, 30 Apr 2024 13:38:14 +0000 https://www.sparkxgroup.cloud/?p=12959 State legislatures have already been busy this year. Here are some topics and bills Spark experts have been watching closely. … Read More

The post Revenue Cycle Impacts: 2024 State Legislation appeared first on Spark Health Partners.

]]>

At Spark Health Partners, we track regulatory updates in the healthcare industry to keep our operators informed and ensure our partners have the information they need to stay ahead of the changing legislation.

It’s still early in 2024, but state legislatures have already been busy this year. Here are some topics and bills that our experts have been watching closely.

Patient Medical Debt Collection

  • ConnecticutRaised SB 395 would prohibit health care providers from reporting medical debt to credit rating agencies. It would also require providers to include in any contracts with debt collection entities a provision which would prohibit those entities from credit reporting. This legislation has so far passed the Senate. If it becomes law, it would be effective July 1, 2024.
  • FloridaHB 7089 establishes a three-year statute of limitations to collect medical debt, and exempts medical debt from legal process including attachment, garnishment, or legal process in an action on medical debt. This bill has passed the legislature but has not yet been presented to Governor Ron DeSantis as of the conclusion of the 2024 Regular Session. Once presented, Governor DeSantis will have 15 days to take action.
  • MaineSP 908 prohibits health care providers from charging any interest on debt or fees in connection with collection of medical debt. It also prohibits debt collectors from pursuing litigation to compel payment of medical debt without providing proof that the consumer was sent a certain written notice, given at least 30 days to respond, and when the consumer’s household income is not more than 300% of the Federal poverty guidelines. This bill was recently approved by the governor and will become effective 90 days after adjournment of the legislative session.
  • New JerseyA3760 or the “Medical Debt Homestead Protection Act” prohibits forced home sales in cases of bankruptcy resulting from medical debt. S2806/A3861 or the “Louisa Carman Medical Debt Relief Act” prohibits medical debt collectors from reporting medical debt to consumer reporting agencies as of the effective date (not provided), as well as prohibits consumer reporting agencies from reporting medical debt less than $500 regardless of when the debt was incurred. A3513 caps the medical debt interest rate as the lessor of (i) “the annual rate equal to the weekly average one-year constant maturity Treasury yield, as published by the Board of Governors of the Federal Reserve System, for the calendar week preceding the date when the consumer was first provided with a bill” or (ii) 3%. All bills are pending committee review.
  • South CarolinaHB 4571 would prohibit consumer credit reporting agencies from using in its consumer credit report any information concerning medical debt. This bill has been with the House Committee on Labor, Commerce and Industry since January.
  • TennesseeHB 1957 would prohibit consumer reporting agencies from including on a consumer report a record of medical debt. It would also require providers and facilities to ensure that any amount of outstanding patient date that equals the amount of public funds accepted is designated as satisfied and that patient is notified of such satisfaction of their debt. Lastly, it would prohibit providers and facilities from seeking judgment or taking other legal action to collect medical debt. This bill recently failed in the Senate Commerce and Labor Committee.
  • Virginia – Virginia passed two new laws relating to medical debt during its session. HB 1370 prohibits facilities, providers, emergency medical services agencies, and debt collection entities from reporting any portion of a medical debt to a consumer reporting agency. HB 34 establishes a three-year statute of limitations from the final invoice due date to collect medical debt unless there is a contract for a payment plan that allows for a long period of time for collection. Where there is a breach of a payment plan, an action is barred if not started within three years from the date of breach. Both laws become effective July 1, 2024.
  • WisconsinAB 786 would have prohibited health care providers, billing administrators, and debt collector acting on behalf of the provider from reporting a medical debt to a consumer reporting agency unless 1) the health care provider provided a written statement to the patient describing the unpaid amount and including the name and address of the health care provider that provided the services, 2) six months have passed since the due date listed on that statement, and 3) the patient does not dispute the charges. This bill recently failed to pass the Senate.

Downcoding

  • ConnecticutRaised SB 405 would require payers that contract with a health care provider on or after July 1, 2025, to include in their contract a provision that prohibits the payer from downcoding any claim submitted by the health care provider. This bill is with the Senate, which held a Public Hearing about it in March.
  • Florida – Although these bills died in committee during Florida’s legislative session, HB 1475/SB 1574 would have prohibited insurers from downcoding (unless otherwise permitted in the participation agreement) if the service was ordered by a provider in-network with the applicable health plan. If permitted by the participation agreement, the payment adjudicator would have needed to meet additional requirements.
  • New Jersey – As introduced, Bill S594 and Bill A1036 would prohibit payers from downcoding in a manner that would prevent a health care provider from submitting a claim for the services performed and collecting reimbursement from the payer for that service. Both bills are pending committee review.

Prior Authorization

  • ArizonaHB 2726 would require that, in the event a patient changes insurance, if the prior insurer approved a prior authorization for a covered service, the new health care insurer must also honor the prior authorization for the first 90 days of the member’s health insurance coverage. Also imposes requirements for publication and notification of requirements and changes to the same. Further, makes prior authorization valid for at least six months from the date the health care insurer receives the prior authorization or the length of the treatment and remains in effect regardless of any changes in the prescription dosage. This bill has been assigned to the HHS and Rules Committees and is pending review.
  • ConnecticutRaised HB 5460 would prohibit insurers from (1) requiring prior authorizations after any transport when medically necessary by ambulance to a hospital, and (2) denying payment to ambulance providers on the basis that the enrollee failed to obtain a prior authorization. This bill is currently with the House Joint Committee on Insurance and Real Estate, which held a hearing about it in March.
  • Florida – Although these bills also died in committee during Florida’s legislative session, HB 1475/SB 1574 would have required insurers to establish an electronic prior authorization process for accepting prior authorization requests.
  • KansasHB 2713 would impose certain requirements and limitations on the use of prior authorization for healthcare services. This bill has been referred to Committee on Interstate Cooperation and is pending review.
  • KentuckyHB 317 would have established a prior authorization exemption program including, for example, a requirement that a health care provider be exempted when they have a 90% approval history during a specific timeframe. This proposed “gold card” program was supported by both the Kentucky Hospital Association and the Kentucky Medical Association, but Beckers recently reported that this bill failed.
  • MaineHP 485/LD 796 requires health plan carriers to establish and maintain a grievance procedure for resolution of prior authorization denials where such procedures must include notice to the enrollee’s provider of a prior authorization denial. The law further requires that if a covered medically necessary service cannot be delivered on the approved date of an approved prior authorization request, a carrier cannot deny the claim if the service is provided within 14 days before or after the approved date. If non-emergency services within scope of a patient’s coverage are provided without a required prior authorization approval, the carrier cannot deny the claim pending medical necessity review and may not impose a penalty on the provider for failing to obtain a prior authorization greater than 15% of the contractually allowed amount for the services. This new law also establishes other requirements and limitations around prior authorization processes and imposes certain new reporting requirements on health carriers about their prior authorization requirements. This bill became law without the governor’s signature on May 1, 2024. Bills in Maine become effective 90 days after the end of the legislative session in which it was passed; here, that will be mid-July.
  • MissouriSB 983 provides that a health carrier or utilization review entity shall not require health care providers to obtain prior authorization for health care services, except under certain circumstances. Similarly, HB 1976 adds additional requirements for prior authorization, including a 6 month evaluation period, notifications, determination parameters, and online portal access. Both bills are pending committee review and advancement.
  • New HampshireSB 561 seeks to establish parameters around the use of prior authorization while also standardizing and streamlining those processes. Among the different requirements, the law would require a prior authorization to be valid for 60 business days from the date of issuance. It would also require, with specific exceptions, that health carriers pay contracted health care providers for a health care service which was provided according to a prior authorization determination. This bill has passed the Senate, and the House Commerce and Consumer Affairs Committee recently held a Public Hearing about it.
  • New JerseyS530 or the “New Jersey Respect for Physicians Act” seeks to create requirements with respect to promptness of insurer responses to prior authorization requests. This bill has been referred to Senate Commerce Committee and is pending review.
  • New MexicoSB135 prohibits prior authorization for FDA-approved prescription drug treatment for an autoimmune disorder or cancer (in addition to SUDs, which is currently provided), unless the generic version is available. This bill passed and was signed into law March 1, 2024. The law applies to plans issued for delivery or renewed on or after January 1, 2025.
  • TennesseeSB 2014 requires that health plans must adhere to 72-hour waiting period prior to imposing as a condition of coverage that the provider promptly contact the health insurer for prior authorization for continued treatment and other care for an enrolled patient. This bill has been referred to the Senate Commerce and Labor Committee.
  • VirginiaSB 98/HB 1134 requires that provider contracts with carriers include a specific provision that prohibits carriers from revoking, limiting, conditioning, modifying, or restricting any prior authorization it approved for a prescription drug which has been scheduled, provided, or delivered to the patient consistent with the authorization. This new law becomes effective July 1, 2024.

Keeping you informed

  • Shifting regulations can be difficult to follow but monitoring them is critical; any impact to the healthcare industry represents an impact to our clients. Spark is committed to tracking new legislation as it is drafted and passed. Stay abreast of these latest developments by subscribing to our monthly newsletter, Spark Exclusive.

Get the latest insights

Spark’s monthly newsletter keeps you ahead of the curve with unique perspectives and actionable insights about the issues at the top of your agenda.

These materials are for general informational purposes only. These materials do not, and are not intended to, constitute legal or compliance advice, and you should not act or refrain from acting based on any information provided in these materials. Neither Spark Health Partners, nor any of its employees, are your lawyers. Please consult with your own legal counsel or compliance professional regarding specific legal or compliance questions you have.

The post Revenue Cycle Impacts: 2024 State Legislation appeared first on Spark Health Partners.

]]>
CMS Tightens Prior Authorization Time Frame in Final Rule https://www.sparkxgroup.cloud/blog/prior-authorization-time-frame-cms/ Tue, 30 Jan 2024 19:50:13 +0000 https://www.sparkxgroup.cloud/?p=12621 Health plans will be required to meet a prior authorization time frame as short as 72 hours, along with providing reasoning for any denials. … Read More

The post CMS Tightens Prior Authorization Time Frame in Final Rule appeared first on Spark Health Partners.

]]>

What you need to know

Certain types of health plans will be required to provide decisions on prior authorizations within 72 hours (for urgent requests) and seven calendar days (for standard requests), along with reasoning for any denials. These payers must also implement new APIs to streamline electronic prior authorization processes. Operational processes will take effect in 2026 with compliance dates in 2027. This is a welcome regulation in the American healthcare industry where 94% of physicians reported that prior authorization led to delays in patient care, and 46% said these policies led to urgent or emergency care.

The Centers for Medicare & Medicaid Services (CMS) recently released a final rule tightening the prior authorization time frame for certain plan types, including Medicare Advantage Organizations, Medicaid Fee-For-Service (FFS) and managed care programs, Children’s Health Insurance Program (CHIP) FFS and managed care programs, and Qualified Health Plan (QHP) issuers on the Federally Facilitated Exchanges (FFEs).

The CMS Interoperability and Prior Authorization Final Rule outlines new deadlines for prior authorization decisions, specifically 72 hours for urgent requests and seven calendar days for standard requests. Previously, these time frames for response could vary between different plan types and managed care plans.

New transparency provisions mean that impacted payers must also provide insights into:

  • Reasons for care denials: CMS will now require impacted payers to send notices to providers when they make a decision, including a specific reason for denial when they deny a prior authorization request.
  • Prior authorization programs as a whole: Aggregated metrics from each health plan must be publicly reported each year.

In addition to adhering to the new prior authorization time frame, impacted payers must also implement Prior Authorization, Patient Access, Provider Access, and Payer-to-Payer APIs. In an industry with an increasing focus on interoperability, these new standards go a long way toward facilitating communication and improving data-sharing for the benefit of patient care and treatment.

Impact: removing barriers to patient care

The final rule deals with the logistics of deadlines and technological interoperability, yet it is patients and providers who are intended to benefit the most. This is because the final rule’s main components are focused on standardization and transparency with the goal of reducing the burden of the prior authorization process.
The rule requires payers to provide:

  • Standardized decision timelines: The timeframes for response will encourage payers to better communicate and coordinate with their third-party vendors to whom they may outsource prior authorization decisions. These prior authorization time frames, combined with the requirement to provide a denial reason, will go far to relieve providers of existing burdens relating to chasing payers and their vendors for an answer and related reason.
  • Denial reasons: Providing a denial reason seems obvious, but payers too often do not offer any explanation for why a healthcare provider’s prior authorization request is denied. If anything, payers’ reasons are often conclusory statements and boilerplate text that do not speak to the specifics of their decision in relation to the individual patient’s care and treatment. Payer denials may also use proprietary codes or text, which burdens providers who are left with no option but to decipher a specific payer’s proprietary and inefficient method of communication.
  • Publicly reported metrics: CMS is requiring impacted payers to publicly report certain prior authorization metrics by posting them directly on the payer’s website or via publicly accessible hyperlink(s) on an annual basis. This will enhance transparency and understanding within the industry as to the effectiveness of these rules in promoting interoperability and improving prior authorization processes.

Limitations of the prior authorization time frame final rule

None of the new requirements apply to employer-sponsored health plans, which are the most common type of coverage in the United States, covering approximately 54% of the population. In response to comments, CMS said it encourages these types of plans to voluntarily meet the requirements of the final rule to allow patients they cover to have the same interoperable access to their data as those patients with coverage through impacted payers.

The requirements also do not apply to drugs of any type that could be covered by impacted payers. CMS explained that this is because the standards and processes for issuing prior authorization for drugs differ from those that apply to medical items and services.

Additionally, there are already existing regulations for some impacted payers which require prior authorization responses for drugs within certain timeframes. In the final rule, however, CMS said that it would consider options for future rulemaking to address improvements to the prior authorization processes for drugs.

Options around prior authorization time frame compliance

The requirements of this final rule are optimized towards patients’ and providers’ best interests but will only be as effective as the level of payer compliance. What if payers don’t adhere to the new rules or are otherwise inconsistent in their implementation?

As an initial matter, providers must be able to identify instances of payer noncompliance with these requirements. Identifying noncompliance may require new reporting, as well as effective education and training of utilization management and appeals teams. Training and education on the requirements must include how your organization intends to respond to noncompliance and hold payers accountable. This may include, for example, scripting for appeals.

If the noncompliance is not overturned on appeal, or it continues or is systemic, do providers have any sort of regulatory recourse? CMS addressed this question in the final rule, noting that many commenters expressed concern regarding the lack of a proposed mechanism to ensure compliance.

CMS said that its oversight and compliance procedures and processes vary among the different impacted payers, and CMS may consequently take different compliance and enforcement actions. Depending on the plan type, CMS said that patients and providers “may submit an inquiry or complaint to the appropriate authority.”

To effectively file a complaint for noncompliance with these requirements, providers will need to be able to identify the plan type and then the appropriate regulatory authority. This will vary, and Spark’s payer strategy team can help.

Encouraging provider + hospital adoption

To encourage provider adoption of electronic prior authorization processes, the final rule requires a new measure for Merit-based Incentive Payment System (MIPS) eligible clinicians under the Promoting Interoperability performance category of MIPS, as well as for eligible hospitals and critical access hospitals (CAHs) under the Medicare Promoting Interoperability Program.

The new measure will ask clinicians and hospitals to attest “yes” to requesting a prior authorization electronically through a Prior Authorization API during the Calendar Year 2027 performance period.

A better outcome for patients + providers

Existing processes are unsustainable. They unfairly and unnecessarily burden providers with the onerous task of navigating each payer’s prior authorization requirements from submission, data requirements and appeal of inappropriate denials.

The entire process wrongfully detracts limited and valuable resources away from patient care and contributes to provider burnout. It imposes a substantial financial burden on providers who must employ teams of individuals to assist in navigating the disparate prior authorization processes between payers. Most critically, these payer processes cause delays in patient care and treatment plans, which can directly lead to patient harm.

At Spark Health Partners, we fervently support the newly published final rule from CMS. Regulatory efforts to standardize, automate and streamline prior authorization processes help ensure patients receive timely access to necessary care and work to remove undue burden from healthcare providers.

These materials are for general informational purposes only. These materials do not, and are not intended to, constitute legal or compliance advice, and you should not act or refrain from acting based on any information provided in these materials.Neither Spark Health Partners, nor any of its employees, are your lawyers.Please consult with your own legal counsel or compliance professional regarding specific legal or compliance questions you have.

Get the latest insights

Spark’s monthly newsletter keeps you ahead of the curve with unique perspectives and actionable insights about the issues at the top of your agenda.

The post CMS Tightens Prior Authorization Time Frame in Final Rule appeared first on Spark Health Partners.

]]>
Spark’s AI Impact​ ../../../../wp-content/uploads/2024/10/Infographic_AI-in-2023.pdf#new_tab Tue, 16 Jan 2024 13:12:10 +0000 https://www.sparkxgroup.cloud/?p=13462 See how Spark is actually applying AI to drive value across the entire revenue cycle. … Read More

The post Spark’s AI Impact​ appeared first on Spark Health Partners.

]]>
A snapshot of how we’re actually applying AI to drive value across the revenue cycle​

The post Spark’s AI Impact​ appeared first on Spark Health Partners.

]]>
OIG Increases Scrutiny on Medicare Advantage Coding https://www.sparkxgroup.cloud/blog/oig-medicare-advantage-coding/ Fri, 27 Oct 2023 17:46:35 +0000 https://www.sparkxgroup.cloud/?p=12334 Federal agencies are scrutinizing Medicare Advantage coding with inaccurate diagnoses for enrollees with certain high-risk diagnoses. … Read More

The post OIG Increases Scrutiny on Medicare Advantage Coding appeared first on Spark Health Partners.

]]>

Federal agencies have recently increased their focus on Medicare Advantage (MA) plan compliance with federal coding requirements, and specifically, the reporting of inaccurate diagnoses codes for enrollees with certain high-risk diagnoses, resulting in increased (though incorrect) payments from Medicare.

So far this year, OIG has audited nine MA plans for coding compliance issues with these high-risk diagnoses codes, and has generally found that MA plans failed to comply with Federal requirements when submitting these codes.

Plan-specific overpayments + false claims

When analyzing a sample audit of Aetna claims, OIG found that patient medical records did not support the diagnoses codes submitted by Aetna. OIG calculates that Aetna is responsible for $632,070 in overpayments associated with the sample reviewed, and as a result estimates that Aetna received at least $25.5 million in overpayments for 2015 and 2016.

Similarly, Cigna has agreed to settle allegations brought by the Justice Department claiming that Cigna violated the False Claims Act by submitting false diagnosis codes and failing to withdraw inaccurate diagnosis codes for enrolled Medicare Advantage patients, resulting in increased Medicare payments.

Specifically, for payment years 2014 to 2019, Cigna allegedly engaged professional healthcare coders to conduct retroactive “chart reviews” which resulted in the submission of previously un-reported additional diagnosis codes to CMS. Moreover, DOJ highlighted that these chart reviews conducted by Cigna also failed to substantiate the diagnoses codes previously submitted by providers before billing Medicare.

Additionally, for payment years 2016 to 2021, DOJ alleges that Cigna “knowingly submitted and/or failed to delete inaccurate and untruthful diagnosis codes for morbid obesity (ICD-10 E66.01 & E66.2, ICD-9 278.01 & 278.03).” As a result, Cigna allegedly utilized the chart reviews to bolster payments with the reporting of additional diagnoses codes while simultaneously failing to report overpayments using the same captured information.

Correction + next steps

OIG recommends that MA plans identify and refund any overpayments while continuing to examine and improve compliance procedures. In July, OIG added to its Work Plan a “Medicare Part C High-Risk Diagnosis Codes Tool Kit.” OIG explained that it will develop this resource to assist MA plans with analyzing the accuracy of data received from providers, and this will be a starting point from which MA plans can research enrollees who receive diagnoses that are at high risk for being miscoded and then take appropriate action as needed.

In light of this increased enforcement activity for MA plans and the OIG toolkit which (when developed) will assist MA plans in analyzing provider coding, it is likely that providers will experience heightened attention in this area, including an increase in pre-payment and post-payment audits by MA plans. As such, from a practical perspective, providers should ensure that proper coding processes and procedures are in place to avoid noncompliance when submitting claims to MA plans.

These materials are for general informational purposes only. These materials do not, and are not intended to, constitute legal or compliance advice, and you should not act or refrain from acting based on any information provided in these materials. Neither Spark Health Partners, nor any of its employees, are your lawyers. Please consult with your own legal counsel or compliance professional regarding specific legal or compliance questions you have.

Get the latest insights

Spark’s monthly newsletter keeps you ahead of the curve with unique perspectives and actionable insights about the issues at the top of your agenda.

The post OIG Increases Scrutiny on Medicare Advantage Coding appeared first on Spark Health Partners.

]]>
Clarification of the Two-Midnight Rule: A Win for Physician Advisory https://www.sparkxgroup.cloud/blog/two-midnight-rule-qa/ Wed, 25 Oct 2023 16:13:39 +0000 https://www.sparkxgroup.cloud/?p=12284 The 2024 Medicare Advantage Final Rule clarifies that Medicare Advantage (MA) plans must follow the Two-Midnight Rule set in 2013, and more. … Read More

The post Clarification of the Two-Midnight Rule: A Win for Physician Advisory appeared first on Spark Health Partners.

]]>

The CMS 2024 Medicare Advantage and Part D Final Rule (known as CMS-4201-F) clarifies, among other elements, that Medicare Advantage (MA) plans must follow the Two-Midnight Rule set in 2013. This original rule established standard time-based criteria for MA programs to help determine a patient’s inpatient or outpatient status.

CMS-4201-F also makes it so that shorter-stay, case-by-case exceptions to the Two-Midnight Rule (first implemented for other programs in 2016) as well as the Inpatient Only List (IPOL) also now apply to MA plans. In addition, if a patient would qualify for SNF coverage under fee-for-service Medicare, MA plans will now also have to qualify.

These changes make physicians’ lives easier, and could improve the patient experience, as well, in the sense that there may be fewer status changes with simpler rules.

History of the Two-Midnight Rule

Medicare Advantage programs have exploded in market share over the past decade or so. These programs implemented coverage criteria that were often different — more stringent — than traditional fee-for-service Medicare. A noticeable effect was the rise in the percentage of patients in a hospital that were hospitalized as observation. As this trend continued, operating margins of health systems started to dwindle.

In 2013, Medicare attempted to simplify for clinicians whether to hospitalize a patient as inpatient or outpatient (with observation services). This resulted from legal actions from beneficiaries who were concerned they were being kept for observation when they should have been inpatient. This is important because those who are inpatient have certain rights, such as appeal rights and Skilled Nursing Facility (SNF) coverage rights. There were also greater financial liabilities as an outpatient versus being inpatient. Therefore, CMS implemented the Two-Midnight Rule.

For the first time, a patient’s status was no longer just about intensity of service or severity of illness – it is actually based on time, and more specifically the number of midnights a patient was expected to spend in the hospital for hospital care.

Ostensibly, this was a welcome change because it made it much easier for physicians. They could look at their watch and say that a patient had stayed two midnights for hospital services, or that they were expected to stay two midnights, and therefore make them inpatient.

Clarification of the Two-Midnight Rule within the 2024 Final Rule

MA programs never fully adopted time-based criteria, however. They instead looked to their contracts with CMS, which allowed them to create their own criteria for inpatient versus observation (OBS).

Those in Physician Advisory roles have been urging CMS by writing commentaries or speaking to leaders about the unfairness of some of the criteria used by MA.

Finally, on April 5, 2023, after a comment period, CMS came out and clarified that MA plans must follow the Two-Midnight Rule in addition to other important changes:

  • Case-by-case exceptions: In 2016, a big rule came along that said a patient actually don’t have to stay two midnights — it’s called the “case-by-case exception” through which, if a doctor thinks a patient needs to be inpatient because they’re at such a high risk, but doesn’t expect them to stay two midnights, it’s still okay to admit that patient as an inpatient. That also now applies to MA plans.
  • Inpatient Only List (IPOL): IPOL also now applies to MA plans. This was one example where CMS actually made things easier and said that if the procedure you have is on this IPOL, then you will get inpatient payment regardless of how long the patient stays, provided there is an inpatient order. Again, previously MA plans had their own criteria for surgical statusing and none of them really followed the IPOL. But now, CMS is clarifying that MA plans also have to follow IPOL.
  • SNF coverage: If a patient would qualify for SNF coverage under fee-for-service Medicare, now MA plans would also have to qualify.

These are seismic changes, and it’s great to have this clarity. Whether from a hospital standpoint, a patient standpoint or as a physician, it’s not only clarifying, but it’s simplifying criteria, at least on the surface.

Real world changes for real-life impacts

The clarifications made within CMS-4201-F have wide-ranging impacts, from administration to patients to providers.

Impact: Hospitals and patients

An increase in inpatient status at discharge is likely. The average length of stay for a hospitalization in America is about 4.5 days. This naturally crosses two midnights. Before CMS-4201-F, OBS patients could be languishing many days in OBS because they didn’t “meet” MCG or they didn’t “meet” InterQual.

Now, if a patient is receiving medically necessary hospital services after two midnights, they should be upgraded to inpatient — an important distinction.

Impact: Financial

From a financial standpoint, there may be an opportunity to classify more patients as inpatients than before. To hospitals, this is a positive, as an inpatient designation generally pays more than observation.

There is also a financial impact to patients. For example, if you are hospitalized as observation, you must pay coinsurance each time. Additionally, certain medications that you take in the hospital may not be covered.

Essentially if a patient comes in for observation/outpatient, they are at more financial risk because their coinsurance applies each time they go to the hospital, and because their medications given during the stay may not be covered. Whereas if they are considered inpatient, Medicare will pay for the stay, including medications, for the first 60 days after the deductible has been met.

Importantly, if an inpatient disagrees with discharge, they’re able to appeal to the Quality Improvement Organization (QIO). Those are rights that are only afforded to inpatients. So, by ostensibly making inpatient easier, these rights are now restored to patients who previously would have been OBS.

Impact: Physicians

All of these changes better align with clinicians’ decision-making, enabling them to go with what they know is right for each patient versus fighting with insurance companies that don’t have clear criteria set for why or why not they are reimbursing in a certain way. CMS has always deferred — and they remind readers in this latest regulation — that the decision to admit is a complex medical judgment to be made by the physician.

This is really important because, before the Two-Midnight Rule, admittance decisions were based on commercial criteria. Criteria may say if a patient gets a certain rate of IVF, a certain number of packed Red Blood Cells, a certain liter of oxygen, etc., they can now be inpatient.

But for the doctor at the bedside, they should be able to look at the entirety of the patient, including the presenting symptoms, labs, x-rays, physical exam, risk of adverse events and say, “In my judgment this should be inpatient.” Not only that, but seeing somebody spend days and days in OBS just because they didn’t “meet criteria” can be very frustrating.

Now, a doctor can say, “I expect, in my clinical judgment, this patient to stay two midnights or two midnights have passed for hospital level services. I now can confidently make this patient inpatient.” So, it does bring simplicity, when the vast majority of bedside physicians have no idea how to work commercial criteria tools. The Two-Midnight Rule should make more sense to these same physicians.

Impact: Denials

MA plan denials are not an infrequent occurrence. The OIG looked at denials from 2014 to 2016 and found that only 11% of these denials were ever appealed. However, the MA plan themselves overturned 75% of these appeals. This seems to indicate there are too many inappropriately denied services to begin with. Once there was pushback, the vast majority got overturned.

It was never really intended that MA plans would wield this kind of latitude to deny, and in fact the language being used is that MA plans cannot be more restrictive in covering traditional Medicare benefits than Medicare FFS. The language was always there and CMS-4201-F clarifies, enforces and codifies this key point.

What’s the next big change?

After many Physician Advisors wrote letters during the comment period to CMS supporting the Two-Midnight Rule, many of those same experts then wrote a second letter about the need to reform the prior authorization process.

Different payers have different prior auth processes and algorithms, which causes tremendous administrative burdens for all involved. Even more alarming, there may be direct patient harm due to delays in starting treatment plans as physicians wait for approval. Simplifying prior authorizations is the right next goal.

Dr. Khiet Trinh is the Chief Physician Advisor for Spark Health Partners. He is clinically active as a board-certified Family Physician and is also board-certified in Physician Advisory.

Get the latest insights

Spark’s monthly newsletter keeps you ahead of the curve with unique perspectives and actionable insights about the issues at the top of your agenda.

The post Clarification of the Two-Midnight Rule: A Win for Physician Advisory appeared first on Spark Health Partners.

]]>
Congress Investigates OIG Report That Medicaid MCOs Deny Prior Authorizations at Higher Rates https://www.sparkxgroup.cloud/blog/oig-report-finds-medicaid-mcos-deny-prior-authorizations-at-higher-rates-is-new-rulemaking-on-the-horizon/ Tue, 03 Oct 2023 20:25:55 +0000 https://www.sparkxgroup.cloud/?p=11809 A report from the OIG found some MCOs have unusually high rates of prior authorization denials, with limited or no state oversight. … Read More

The post Congress Investigates OIG Report That Medicaid MCOs Deny Prior Authorizations at Higher Rates appeared first on Spark Health Partners.

]]>

This article was originally published August 2023 and updated October 2023 to reflect latest developments.

Congressional leaders have launched a new investigation of the largest Medicaid Managed Care Organizations (MCOs) following an OIG report that raised concerns about MCOs increasing profits by denying requests for care.

Congress recently issued letters to Aetna, AmeriHealth Caritas, CareSource, Centene Corporation, Elevance, Molina Healthcare, and United Healthcare requesting documentation on a variety of topics, including:

  • Prior authorization requirements for Early and Periodic Screening, Diagnostic and Treatment (EPSDT) services across its subsidiary health plans
  • A description of all algorithms used in prior authorization decisions separated by approvals, partial denials, and full denials
  • The rate of appeals by level of appeal and the outcome for Medicaid MCOs and for its Medicare Advantage products

This investigation follows on the heels of a July 2023 report from the Department of Health and Human Services (HHS) Office of Inspector General (OIG), which found that some Medicaid Managed Care Organizations have unusually high rates of prior authorization denials, and there’s limited or no state oversight of these denials.

Background: July Report Shed Light on Medicaid MCOs

Looking at 2019 data, OIG found that MCOs generally denied one out of every eight requests for prior authorizations. Among 115 MCOs reviewed, 12 had prior authorization denial rates greater than 25%—twice the overall rate.

For comparison, OIG noted the overall denial rate for Medicare Advantage (MA) plans was only 5.7% of requests in 2019. OIG stated the factors it reviewed “raise concerns that some people enrolled in Medicaid managed care may not be receiving all medically necessary health care services intended to be covered…”

CMS Updates to MA Plan Requirements

The Centers for Medicare & Medicaid Services (CMS) issued a Final Rule in April that requires MA plans to follow traditional Medicare laws for coverage decisions and limits the use of prior authorization, among other changes.

Spark Health Partners’ team of subject matter experts shared insight into these changes and their potential impact on providers.

For that Final Rule, CMS relied in no small part on an April 2022 report issued by OIG titled, “Some Medicare Advantage Organization Denials of Prior Authorization Requests Raise Concerns About Beneficiary Access to Medically Necessary Care.” Based upon that report, CMS issued new rules to act as guardrails to ensure MA plans use utilization management tools and make associated coverage decisions, in ways that ensure beneficiaries’ timely and appropriate access to medically necessary care.

OIG Recommendations + Potential Actions

In July 2023, the OIG issued a similar report, but this time examined the high rates of prior authorization denials by Medicaid MCOs. In its report, OIG recommended CMS require states to exercise more oversight over prior authorization denials through regular review of denial samples, required data reporting from MCOs, issuance of guidance and implementation of automatic requirements for external review. This could lead to future rulemaking from CMS to curb this behavior from Medicaid MCOs.

The OIG’s recommendations primarily focus on state oversight. However, it may be appropriate for additional rulemaking to require states to establish their own guardrails around MCOs. These guardrails would ensure prior authorization decisions align with state Medicaid standards for medical necessity and limit when MCOs may use their own internal coverage criteria to deny beneficiary access to care.

State Obligations + CMS Initiatives for Medicaid Beneficiaries

Under federal law, states must ensure all services covered under each state Medicaid plan are available and accessible to enrollees of MCOs in a timely matter. Federal law also requires contracts between a state and MCO to specify what constitutes “medically necessary services,” and be no more restrictive than what’s used by the state Medicaid program.

Acting on OIG’s recommendations and possibly taking these additional steps, CMS could ensure Medicaid beneficiaries have timely access to medically necessary services similar to its attempt to do for Medicare Advantage beneficiaries.

________________________________________

Cara Tucker has been an attorney for over 10 years, specializing in healthcare and regulatory compliance. She currently serves as legal counsel managing regulatory updates at Spark Health Partners, developing legally based strategies and procedures to holistically resolve systemic payor issues to increase revenue, reduce administrative burdens and mitigate risk for providers.


 

These materials are for general informational purposes only. These materials do not, and are not intended to, constitute legal or compliance advice, and you should not act or refrain from acting based on any information provided in these materials. Neither Spark Health Partners, nor any of its employees, are your lawyers. Please consult with your own legal counsel or compliance professional regarding specific legal or compliance questions you have.

The post Congress Investigates OIG Report That Medicaid MCOs Deny Prior Authorizations at Higher Rates appeared first on Spark Health Partners.

]]>
2024 Medicare Advantage Program Changes: What You Need to Know https://www.sparkxgroup.cloud/blog/2024-medicare-advantage-program-changes-what-you-need-to-know/ Tue, 18 Jul 2023 15:41:09 +0000 https://www.sparkxgroup.cloud/?p=11374 This new rule introduces several key changes that will promote transparency and consistency in healthcare coverage decisions. … Read More

The post 2024 Medicare Advantage Program Changes: What You Need to Know appeared first on Spark Health Partners.

]]>

CMS Final Rule Analysis 

On April 5, 2023, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that requires Medicare Advantage (MA) plans to follow traditional Medicare laws for coverage decisions. It also limits the use of prior authorization, mandates continuity of care for Medicare beneficiaries and establishes a Utilization Management (UM) Committee with a heightened standard for adverse medical necessity decisions. 

The final rule is technically effective as of June 5 2023, although the new utilization management requirements are applicable to coverage beginning Jan. 1, 2024. 

This move is seen as a positive development for healthcare providers, as it brings MA plans closer in alignment with traditional Medicare, which many consider to be the gold standard. 

Spark Health Partners’ team of subject matter experts created a quick reference guide with clear and easy-to-understand insights into the MA program changes and their potential impact on you.  

Key Takeaways 

  • MA plans must comply with traditional Medicare coverage criteria requirements and standards. This Final Rule makes regulations clearer in what adherence looks likes, codifies what CMS already thinks and limits when MA plans may create and use their own internal coverage criteria. It adds transparency to coverage determinations for providers and beneficiaries.

  • MA plans can only use the prior authorization process to validate medical necessity and clinical appropriateness of service. MA plans can’t later deny coverage of an item or service based on medical necessity if it previously issued a prior authorization for that item or service. 

  • MA plans must establish a UM committee to review and approve all UM policies and procedures to ensure alignment with traditional Medicare. UM policies and procedures cannot be used for basic or supplemental benefits on or after Jan. 1, 2024, unless those policies and procedures have been reviewed and approved by the UM committee. 

This new rule introduces several key changes that will promote transparency and consistency in healthcare coverage decisions for MA beneficiaries while ensuring healthcare providers are able to provide the best possible care to their patients. Download this quick reference guide to prepare for these changes and hold MA plans accountable to the new requirements. 

View the quick reference e-book here. 


 

These materials are for general informational purposes only. These materials do not, and are not intended to, constitute legal or compliance advice, and you should not act or refrain from acting based on any information provided in these materials. Neither Spark Health Partners, nor any of its employees, are your lawyers. Please consult with your own legal counsel or compliance professional regarding specific legal or compliance questions you have.

The post 2024 Medicare Advantage Program Changes: What You Need to Know appeared first on Spark Health Partners.

]]>